Atea Pharmaceuticals, Inc. (AVIR) Presents at Morgan Stanley 24th Annual Global Healthcare Conferenc

BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Compan

BlackRock Inc. purchased a new position in Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) during the seco

Atea Pharmaceuticals, Inc. (AVIR) Q2 2026 Earnings Call Transcript

Atea Pharmaceuticals NASDAQ: AVIR reported positive top-line results from its Phase III C-BEYOND tri

Phase 3 C-BEYOND Trial Met Primary and Secondary Endpoints, with a Short 8-week Duration for Patient

BOSTON, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company

Atea Pharmaceuticals announced positive Phase 3 C-BEYOND trial results for its oral hepatitis C comb

Bemnifosbuvir/Ruzasvir (BEM/RZR) Achieved its Primary Endpoint of Statistical Non-inferiority Compar

Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Health

Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark

Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naï

Atea Pharmaceuticals (AVIR) might move higher on growing optimism about its earnings prospects, whic

Here is how Atea Pharmaceuticals, Inc. (AVIR) and Design Therapeutics, Inc. (DSGN) have performed co

Atea Pharmaceuticals, Inc. receives a buy rating ahead of pivotal phase 3 BEM/RZR hepatitis C data e

BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company)

Atea Pharmaceuticals (AVIR) has become technically an oversold stock now, which implies exhaustion o

BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company)

Atea Pharmaceuticals, Inc. (AVIR) Q1 2026 Earnings Call Transcript

Atea Pharmaceuticals NASDAQ: AVIR said it remains on track for two key Phase 3 hepatitis C readouts

C-BEYOND Phase 3 North American Trial for Treatment of Hepatitis C Virus (HCV) Remains on Track with

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company)

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

  On Monday, 369 companies set new 52-week lows.

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Friday. Here are some big

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe

  On Friday, 469 companies hit new 52-week lows.

  On Wednesday, 100 stocks hit new 52-week lows.

  During Tuesday, 79 stocks hit new 52-week lows.

  On Friday, 135 companies reached new 52-week lows.

  OnWednesday, 78 stocks made new 52-week lows.

  On Wednesday, 258 companies hit new 52-week lows.

  Monday saw 196 companies set new 52-week lows.

  On Friday, 127 companies set new 52-week lows.

  On Wednesday, 283 companies set new 52-week lows.

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar

  During Wednesday's trading, 517 companies set new 52-week lows.

  On Tuesday, 838 companies hit new 52-week lows.

  During Monday's trading, 528 companies set new 52-week lows.

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly

  On Friday, 1043 companies hit new 52-week lows.